butrin has been researched along with phorbolol myristate acetate in 1 studies
| Studies (butrin) | Trials (butrin) | Recent Studies (post-2010) (butrin) | Studies (phorbolol myristate acetate) | Trials (phorbolol myristate acetate) | Recent Studies (post-2010) (phorbolol myristate acetate) |
|---|---|---|---|---|---|
| 6 | 0 | 3 | 314 | 2 | 127 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, N; Haqqi, TM; Khan, A; Khan, KA; Rasheed, Z | 1 |
1 other study(ies) available for butrin and phorbolol myristate acetate
| Article | Year |
|---|---|
Butrin, isobutrin, and butein from medicinal plant Butea monosperma selectively inhibit nuclear factor-kappaB in activated human mast cells: suppression of tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8.
Topics: Butea; Calcimycin; Chalcones; Chromatography, Thin Layer; Enzyme-Linked Immunosorbent Assay; Flavonoids; Gas Chromatography-Mass Spectrometry; Gene Expression; Humans; I-kappa B Kinase; Inflammation; Interleukin-6; Interleukin-8; Mast Cells; NF-kappa B; Plant Extracts; Plants, Medicinal; Polymerase Chain Reaction; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2010 |